Cardiac Troponin I Levels in Patients with Left Heart Failure and Cor Pulmonale

Abstract

Cardiac troponin levels are regarded as the most specific of currently available biochemical markers of myocardial damage. Elevated levels of troponin have been previously reported in patients with left heart failure, reflecting small areas of undetected myocardial cell death. The aim of this study was to compare the levels of the cardiac troponin I (cTnl) in patients with left- and right-sided heart failure.

Cardiac troponin I levels were studied with immunochemical methods in patients with right heart failure (n = 17) resulting from chronic obstructive pulmonary disease, ischemic left heart failure (n = 23), and nonischemic left heart failure (n = 18) who were admitted to departments of cardiology and chest diseases. Also, cTnl levels were measured in 32 healthy subjects as control group. Protein markers of myocardial injury (cTnl and myoglobin) in patients with left and right heart failure were collected approximately 12 to 36 hours after onset of obvious symptoms. Serum creatine kinase MB band was determined on admission and thereafter twice a day during the first 3 days.

Elevated levels of serum cTnl were found in patients with nonischemic (0.83 ±0.6 ng/mL, p<0.01) and ischemic left heart failure (0.9 ±0.5 ng/mL, p<0.01) when compared to healthy subjects, whereas serum cTnl levels in patients with right heart failure due to chronic obstruc tive pulmonary disease were not significantly different from those of control subjects (0.22 ±0.1 vs 0.16 ±0.1 ng/mL, p> 0.05). In addition, creatine kinase MB band and myoglobin levels were not significantly different between patient and healthy groups.

The mean of cTnl levels in ischemic and even nonischemic left heart failure were increased compared to the mean of values in healthy individuals but without significant creatine kinase MB band and myoglobin elevations. But cTnl levels were not increased in patients with right heart failure due to chronic obstructive pulmonary disease. These data indicate that the cTnl levels are abnormal in left heart failure but not in cor pulmonale.

Get full access to this article

View all access options for this article.

References

Tymchak WJ , Armstrong PW : Spectrum of ischemic heart disease and the role of biochemical markers Clin Lab Med 17:701-725, 1997.

Adams JE , Bodor GS , Davila-Roman, et al : Cardiac troponin I: A marker with high specificity for cardiac injury Circulation 88:101-106, 1993.

Bhayana V. , Gougoulias T. , Cohoe S., et al : Discordance between results for serum troponin T and troponin I in renal disease Clin Chem 41:312-317, 1995.

Adams JE , Sicard GA , Allen BT, et al : Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I N Engl J Med 330:670-674, 1994.

Adams JE , Schectman KB , Landt J., et al : Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I Clin Chem 40:1291-1295, 1994.

Kaumann A. , Bartel S. , Molenaar P., et al : Activation of β2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure Circulation 99:65-72, 1993.

Bodor GS , Oakeley AE , Allen PD, et al : Troponin I phosphorylation in the normal and failing adult human heart Circulation 96:1495-1500, 1997.

Missov E. , Calzolari C. , Pau B. : Circulation cardiac troponin I in severe congestive heart failure Circulation 96:2953-2958, 1997.

Missov E. , Mair J. : A novel biochemical approach to congestive heart failure: Cardiac troponin T Am Heart J 138:95-99, 1999.

10.

La Vecchia L. , Mezzena G. , Ometto R., et al : Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin Am J Cardiol 80:88-90, 1997.

11.

Setsuta K. , Seino Y. , Takahashi N., et al : Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure Am J Cardiol 84:608-611, 1999.

12.

Genote C. , Armstrong S. : Ischemia and the myocyte cytoskeleton: Review and speculation Cardiovasc Res 27:1387-1403, 1995.

13.

Mair J. , Wagner I. , Morass B., et al : Cardiac troponin release correlates with myocardial infarction size Eur J Clin Chem Biochem 33:869-872, 1995.

14.

Ricchiuti V. , Sharkey SW , Murakami MM, et al : Cardiac troponin I and T alteration in dog hearts with myocardial infarction Am J Clin Pathol 110:241-247, 1998.

15.

Cummins B. , Auckland ML , Cummins P. : Cardiac specific troponin I radioimmunoassay in the diagnosis of acute myocardial infarction Am Heart J 113:1333-1344, 1987 .

16.

O'Brien PJ : Deficiencies of myocardial troponin-T and creatine kinase MB isoenzyme in dogs with idiopathic dilated cardiomyopathy Am J Vet Res 58:11-16, 1997.

17.

Chen YN , Wei JR , Zeng LJ, et al : Monitoring of cardiac troponin I in patients with acute heart failure Ann Clin Biochem 36:433-437, 1999.

18.

Piper HM , Schwartz P. , Spahr R., et al : Early enzyme release from myocardial cell is not due to irreversible cell damage J Mol Cell Cardiol 16:385-388, 1984.

19.

Collinson PO : Troponin T or troponin I or CK-MB (or none?) Eur Heart J 19 (suppl N):N16-N24, 1998.

20.

Weber KT , Billa CG : Pathological hypertrophy and cardiac interstitium. Fibrosis and the renin-angiotensin-aldosterone system Circulation 83:1849-1865, 1991 .

21.

Newman JH , Ross JC : Chronic cor pulmonale In: Alexander RW, Schlant RC, Fuster V (eds): Hurst's The Heart. Dubuque IA: McGraw Hill, 1998, pp 1739-1752.

22.

Davila-Roman VG , Guest TM , Tutuer PG, et al : Transient right but not left ventricular dysfunction after strenuous exercise at high altitude J Am Coll Cardiol 30:468-473, 1997.